What Is CAR T-Cell Therapy? CAR T-cell therapy is a type of immunotherapy. CAR stands for chimeric antigen receptor. The therapy is a living treatment that takes your own immune cells and modifies ...

The blood cells can form tumors in these places. Although follicular lymphoma usually can't be cured, you can live long and well with it. This cancer grows slowly. You may not need treatment for ...

A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB ...

Stage 4 lymphoma is a blood cancer that has spread outside of the lymph nodes to other parts of the body. Learn the symptoms, ...

data from a phase I trial of AZD0486-- a novel CD19xCD3 bispecific T-cell engager -- showed high response rates and encouraging safety in relapsed/refractory follicular lymphoma patients ...

2 with transformed follicular lymphoma, 1 with high-grade B-cell lymphoma, and 1 with T-cell histiocyte-rich B-cell lymphoma; 6 patients had follicular lymphoma, and 3 had mantle-cell lymphoma.

Notably, this patient had previously undergone 7 prior lines of therapy including chemoimmunotherapies, CD19 CAR T cells ... and refractory B-cell non-Hodgkin's lymphoma (B-NHL; NCT05370430 ...

When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to treatment for some patients, with its high end durable response rates ...

CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine. Follicular lymphoma is a typically slow ...

PMB-CT01 is a first-in-class, BAFF-R targeted, autologous CAR T cell therapy ... The Institute for Follicular Lymphoma Innovation (IFLI) is a global, non-profit, private foundation dedicated ...